Kraj: Stany Zjednoczone
Język: angielski
Źródło: NLM (National Library of Medicine)
PHENOBARBITAL (UNII: YQE403BP4D) (PHENOBARBITAL - UNII:YQE403BP4D)
Chartwell RX, LLC
ORAL
PRESCRIPTION DRUG
- Sedative Anticonvulsant – For the treatment of generalized and partial seizures. - Sedative - Anticonvulsant – For the treatment of generalized and partial seizures. Phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident. Controlled Substance – Phenobarbital is a Schedule IV drug. Dependence – Barbiturates may be habit forming. Tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses of barbiturates. Daily administration in excess of 400 mg of pentobarbital or secobarbital for approximately 90 days is likely to produce some degree of physical dependence. A dosage of 600 to 800 mg taken for at least 35 days is sufficient to produce withdrawal seizures. The average daily dose for the barbiturate addict is usually about 1.5 g. As tole
Phenobarbital Tablets, USP, 15 mg are white, round, biconvex, scored tablets, debossed “691” below the score on one side and "ECI" on the reverse side. Supplied in bottles of 120 and 500: Phenobarbital Tablets, USP, 16.2 mg (1/4 grain) are white, round, biconvex, scored tablets, debossed “625” below the score on one side and "ECI" on the reverse side, supplied in bottles of 120: Phenobarbital Tablets, USP, 30 mg are white, round, biconvex, scored tablets, debossed “692” below the score on one side and "ECI" on the reverse side. Supplied in bottles of 60 and 500: Phenobarbital Tablets, USP, 32.4 mg (1/2 grain) are white, round, biconvex, scored tablets, debossed “626” below the score on one side and "ECI" on the reverse side, supplied in bottles of 60: Phenobarbital Tablets, USP, 60 mg are white, round, biconvex, scored tablets, debossed "693" below the score on one side and "ECI" on the reverse side. Supplied in bottles of 60 and 500: Phenobarbital Tablets, USP, 64.8 mg (1 grain) are white, round, flat face, bevel edge, scored tablets debossed “627” below the score on one side and "ECI" on the reverse side, supplied in bottles of 60: Phenobarbital Tablets, USP, 97.2 mg (1 1/2 grain) are white, round, flat face, bevel edge, scored tablets debossed “628” below the score on one side and "ECI" on the reverse side, supplied in bottles of 30: Phenobarbital Tablets, USP, 100 mg are white, round, biconvex, scored tablets, debossed “694” below the score on one side and "ECI" on the reverse side. Supplied in bottles of 90 and 500: Manufactured By: ECI Pharmaceuticals, LLC Fort Lauderdale, FL 33309 Manufactured for: Chartwell RX, LLC. Congers, NY 10920 Rev. 08/2022-01 L71044
unapproved drug other
PHENOBARBITAL- PHENOBARBITAL TABLET CHARTWELL RX, LLC _Disclaimer: This drug has not been found by FDA to be safe and effective, and this_ _labeling has not been approved by FDA. For further information about unapproved_ _drugs, click here._ ---------- PHENOBARBITAL TABLETS, USP CIV RX ONLY WARNING: MAY BE HABIT-FORMING DESCRIPTION The barbiturates are nonselective central nervous system (CNS) depressants that are primarily used as sedative-hypnotics. In subhypnotic doses, they are also used as anticonvulsants. The barbiturates and their sodium salts are subject to control under the Federal Controlled Substances Act. Phenobarbital is a barbituric acid derivative and occurs as white, odorless, small crystals or crystalline powder that is very slightly soluble in water; soluble in alcohol, in ether, and in solutions of fixed alkali hydroxides and carbonates; sparingly soluble in chloroform. Phenobarbital is 5-ethyl-5-phenylbarbituric acid. Phenobarbital is a substituted pyrimidine derivative in which the basic structure is barbituric acid, a substance that has no CNS activity. CNS activity is obtained by substituting alkyl, alkenyl, or aryl groups on the pyrimidine ring. It has the following structural formula: Each phenobarbital tablet contains 15 mg, 16.2 mg (1/4 grain), 30 mg, 32.4 mg (1/2 grain), 60 mg, 64.8 mg (1 grain) 97.2 mg (11/2 grain), or 100 mg of phenobarbital. In addition, each tablet contains: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose and sodium starch glycolate. CLINICAL PHARMACOLOGY Barbiturates are capable of producing all levels of CNS mood alteration, from excitation to mild sedation, hypnosis, and deep coma. Overdosage can produce death. In high enough therapeutic doses, barbiturates induce anesthesia. Barbiturates depress the sensory cortex, decrease motor activity, alter cerebellar function, and produce drowsiness, sedation, and hypnosis. Barbiturate-induced sleep differs from physiologic sleep. Sleep laboratory studies have demonstrated th Przeczytaj cały dokument